Healthcare & Medicine
Advancing Medicine. Reclaiming Capital. SR&ED for Ontario MPCs.
SR&ED is no longer just for laboratories. Specialized medical practices and Medical Professional Corporations are increasingly using it to fund clinical innovation, custom health-tech, and procedural advances. Innovotis helps your MPC convert physician salaries and the technical challenges you already solve into non-dilutive capital, so you can scale your practice and lead in patient care.
Why It Matters
How SR&ED creates value for doctors & mpcs
Recover Hidden R&D Costs
Convert a portion of physician salaries and specialized staff wages into liquid cash or tax credits. Roughly $60,000+ comes back per $100,000 of eligible R&D salary spent.
Scale Beyond Patient Billing
Diversify your revenue by developing proprietary methods, digital health tools, or data-driven diagnostic models, funded by credits rather than your operating budget.
Lead in Patient Care Innovation
Reinvest recovered capital into cutting-edge equipment, clinical trials, and procedural refinement, turning research that improves outcomes into a sustainable funding engine.
Audit-Proof Your Innovation
We formalize and document your SR&ED process to the highest CRA standards, so your medical advancements are defensible and your claim holds up to review.
2026 Incentives
The credits you can stack
| Incentive | Rate | Detail |
|---|---|---|
| Federal Enhanced ITC | 35% | Fully refundable on the first $6M of eligible spend, raised from $3M in 2026. |
| Ontario Innovation Tax Credit (OITC) | 8% | Refundable credit for small-to-medium corporations. |
| Ontario R&D Tax Credit (ORDTC) | 3.5% | Non-refundable; offsets Ontario provincial taxes. |
back in combined federal and provincial credits per $100,000 of eligible R&D salary
Eligibility
What qualifies in doctors & mpcs
If your team is resolving genuine technological uncertainty, this work likely counts. Here's what we typically see qualify.
Clinical Trials & Protocols
Developing and testing a new treatment protocol for a specific patient demographic where no established clinical guidelines exist.
Custom Health-Tech
Building proprietary EMR extensions, AI-driven diagnostic triage systems, or remote patient-monitoring software from the ground up.
Procedural Innovation
Modifying standard surgical or clinical procedures to improve patient outcomes in ways not documented in current medical literature.
Pharmacology Research
Investigating novel drug interactions or dosage concentrations that go beyond standard off-label use and resolve genuine technological uncertainty.
Capital Equipment Spend
Capital expenditures are eligible again in 2026, so investments in research equipment and lab infrastructure can now count toward your claim.
What Our Clients Say
Results in Doctors & MPCs
Innovotis demonstrated a unique ability to bridge the gap between healthcare innovation and funding strategy. Their team took the time to understand our research objectives and helped us secure valuable tax credits that strengthened our ability to invest in future development. Their professionalism, responsiveness, and genuine interest in our success stood out from day one.